PubRank

Mark R Emmett

Author PubWeight™ 48.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients. Proc Natl Acad Sci U S A 2009 2.84
2 Key interactions in HIV-1 maturation identified by hydrogen-deuterium exchange. Nat Struct Mol Biol 2004 2.34
3 Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. J Mol Biol 2003 2.32
4 Enhanced digestion efficiency, peptide ionization efficiency, and sequence resolution for protein hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem 2008 1.55
5 Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry. J Biol Chem 2005 1.50
6 Fast reversed-phase liquid chromatography to reduce back exchange and increase throughput in H/D exchange monitored by FT-ICR mass spectrometry. J Am Soc Mass Spectrom 2008 1.43
7 Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy. Anal Bioanal Chem 2007 1.37
8 Automated data reduction for hydrogen/deuterium exchange experiments, enabled by high-resolution Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom 2010 1.28
9 Theoretical and experimental prospects for protein identification based solely on accurate mass measurement. J Proteome Res 2004 1.12
10 Functional visualization of viral molecular motor by hydrogen-deuterium exchange reveals transient states. Nat Struct Mol Biol 2005 1.10
11 Mapping of protein:protein contact surfaces by hydrogen/deuterium exchange, followed by on-line high-performance liquid chromatography-electrospray ionization Fourier-transform ion-cyclotron-resonance mass analysis. J Chromatogr A 2002 1.08
12 Epitope mapping of a 95 kDa antigen in complex with antibody by solution-phase amide backbone hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem 2011 1.04
13 Ion activation in electron capture dissociation to distinguish between N-terminal and C-terminal product ions. Anal Chem 2007 1.04
14 Supercritical fluid chromatography reduction of hydrogen/deuterium back exchange in solution-phase hydrogen/deuterium exchange with mass spectrometric analysis. Anal Chem 2006 1.03
15 Method for lipidomic analysis: p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells. Anal Chem 2007 1.02
16 New reagents for enhanced liquid chromatographic separation and charging of intact protein ions for electrospray ionization mass spectrometry. Anal Chem 2010 1.02
17 Mapping of the allosteric network in the regulation of alpha-isopropylmalate synthase from Mycobacterium tuberculosis by the feedback inhibitor L-leucine: solution-phase H/D exchange monitored by FT-ICR mass spectrometry. Biochemistry 2009 1.00
18 Simultaneous reduction and digestion of proteins with disulfide bonds for hydrogen/deuterium exchange monitored by mass spectrometry. Anal Chem 2010 0.97
19 Dephosphorylation of major sperm protein (MSP) fiber protein 3 by protein phosphatase 2A during cell body retraction in the MSP-based amoeboid motility of Ascaris sperm. Mol Biol Cell 2009 0.93
20 Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation. J Proteome Res 2010 0.90
21 Interaction of packaging motor with the polymerase complex of dsRNA bacteriophage. Virology 2006 0.90
22 Liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance mass spectrometric characterization of N-linked glycans and glycopeptides. Anal Chem 2010 0.90
23 Conformational states of human purine nucleoside phosphorylase at rest, at work, and with transition state analogues. Biochemistry 2010 0.90
24 Drug binding and resistance mechanism of KIT tyrosine kinase revealed by hydrogen/deuterium exchange FTICR mass spectrometry. Protein Sci 2010 0.88
25 De novo sequencing and disulfide mapping of a bromotryptophan-containing conotoxin by Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem 2006 0.88
26 Computing H/D-exchange rates of single residues from data of proteolytic fragments. BMC Bioinformatics 2010 0.87
27 Periodic sequence distribution of product ion abundances in electron capture dissociation of amphipathic peptides and proteins. J Am Soc Mass Spectrom 2009 0.87
28 Protein kinase A phosphorylation characterized by tandem Fourier transform ion cyclotron resonance mass spectrometry. Proteomics 2004 0.86
29 Identification and analysis of phosphopeptides. J Chromatogr B Analyt Technol Biomed Life Sci 2004 0.85
30 Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression. J Proteome Res 2007 0.85
31 Polar aprotic modifiers for chromatographic separation and back-exchange reduction for protein hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom 2012 0.84
32 Use of ENCODE resources to characterize novel proteoforms and missing proteins in the human proteome. J Proteome Res 2014 0.83
33 Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo. Proc Natl Acad Sci U S A 2010 0.83
34 Sequential proteolysis and high-field FTICR MS to determine disulfide connectivity and 4-maleimide TEMPO spin-label location in L126C GM2 activator protein. Anal Chem 2009 0.83
35 Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan. Glycoconj J 2009 0.82
36 Charge location directs electron capture dissociation of peptide dications. J Am Soc Mass Spectrom 2006 0.82
37 Advantages of isotopic depletion of proteins for hydrogen/deuterium exchange experiments monitored by mass spectrometry. Anal Chem 2010 0.82
38 Determining and interpreting correlations in lipidomic networks found in glioblastoma cells. BMC Syst Biol 2010 0.81
39 Characterization of the capsid protein glycosylation of adeno-associated virus type 2 by high-resolution mass spectrometry. J Virol 2006 0.81
40 Expression, purification, and characterization of avian Thy-1 from Lec1 mammalian and Tn5 insect cells. Protein Expr Purif 2004 0.80
41 Structural characterization of an unusually stable cyclic peptide, kalata B2 from Oldenlandia affinis. Biochim Biophys Acta 2006 0.80
42 Liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometric characterization of protein kinase C phosphorylation. J Proteome Res 2003 0.80
43 Structural analysis of 2D-gel-separated glycoproteins from human cerebrospinal fluid by tandem high-resolution mass spectrometry. J Proteome Res 2003 0.77
44 Characterization of the phosphoproteome in androgen-repressed human prostate cancer cells by Fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res 2011 0.77
45 Global stability analysis and robust design of multi-time-scale biological networks under parametric uncertainties. Neural Netw 2009 0.76
46 Complexation and Calcium-Induced Conformational Changes in the Cardiac Troponin Complex Monitored by Hydrogen/Deuterium Exchange and FT-ICR Mass Spectrometry. Int J Mass Spectrom 2011 0.76
47 Sites and extent of selenomethionine incorporation into recombinant Cas6 protein by top-down and bottom-up proteomics with 14.5 T Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom 2010 0.75
48 Identifying bryostatins and potential precursors from the bryozoan Bugula neritina. Nat Prod Res 2005 0.75
49 An antibiotic linked to peptides and proteins is released by electron capture dissociation fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom 2003 0.75